Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging

Parkinsonism and Related Disorders

Volumn 20, Issue 7, 2014, Pages 755-760

  Ohtsuka, Chigumi ^a   Sasaki, Makoto ^a   Konno, Kanako ^a   Kato, Kanako ^a   Takahashi, Junko ^a   Yamashita, Fumio ^a   Terayama, Yasuo ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Differential diagnosis; Magnetic resonance imaging; MIBG scintigraphy; Neuromelanin; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NEUROMELANIN; MELANIN;

ADULT; AGED; ARTICLE; BRAIN REGION; BRAIN SCINTIANGIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA PARS COMPACTA; SYNDROME; WHITE MATTER; DIAGNOSTIC USE; EARLY DIAGNOSIS; METABOLISM; PARKINSONIAN DISORDERS; PATHOLOGY; PROCEDURES; SUBSTANTIA NIGRA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; LOCUS COERULEUS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA;

EID: 84902313846     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.04.005     Document Type: Article

References (28)

1. Hughes A.J., Daniel S.E., Ben Shlomo Y., Lees A.J. The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125(4):861-870.
2. Konagaya M., Konagaya Y., Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. JNeurol Neurosurg Psychiatry 1994, 57:1528-1531.
3. Schrag A., Kingsley D., Phatouros C., Mathias C.J., Lees A.J., Daniel S.E., et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. JNeurol Neurosurg Psychiatry 1998, 65:65-71.
4. Kraft E., Schwarz J., Trenkwalder C., Vogl T., Pfluger T., Oertel W.H., et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?. Arch Neurol 1999, 56:225-228.
5. Massey L.A., Micallef C., Paviour D.C., O'Sullivan S.S., Ling H., Williams D.R., et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012, 27:1754-1762.
6. Seppi K., Schocke M.F. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 2005, 18:370-375.
7. Paviour D.C., Price S.L., Stevens J.M., Lees A.J., Fox N.C. Quantitative MRI measurement of Superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005, 64:675-679.
8. Sasaki M., Shibata E., Tohyama K., Takahashi J., Otsuka K., Tsuchiya K., et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006, 17:1215-1218.
9. Sasaki M., Shibata E., Tohyama K., Kudo K., Endoh J., Otsuka K., et al. Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications. Neuroreport 2008, 19:1649-1654.
10. Ohtsuka C., Sasaki M., Konno K., Koide M., Kato K., Takahashi J., et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett 2013, 541:93-98.
11. Ogisu K., Kudo K., Sasaki M., Sakushima K., Yabe I., Sasaki H., et al. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease. Neuroradiology 2013, 55:719-724.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of Idiopathic Parkinson's disease: a Clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
13. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome):Report of the NINDS-SPSP International Workshop. Neurology 1996, 47:1-9.
14. Gilman S., Low P., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C., et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998, 8:359-362.
15. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
16. Massey L.A., Jäger H.R., Paviour D.C., O'Sullivan S.S., Ling H., Williams D.R., et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013, 80:1856-1861.
17. Wenning G.K., Tison F., Ben Shlomo Y., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997, 12:133-147.
18. Steele J.C., Richardson J.C., Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and dementia. Arch Neurol 1964, 10:333-359.
19. Matsusaka H., Ikeda K., Akiyama H., Arai T., Inoue M., Yagishita S. Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis. Acta Neuropathol 1998, 96:248-252.
20. Komori T., Arai N., Oda M., Nakayama H., Mori H., Yagishita S., et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 1998, 96:401-408.
21. Matsuura K., Maeda M., Yata K., Ichiba Y., Yamaguchi T., Kanamaru K., et al. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy. Eur Neurol 2013, 70:70-77.
22. Kashihara K., Shinya T., Higaki F. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. JClin Neurosci 2011, 18:1093-1096.
23. Orimo S., Suzuki M., Inaba A., Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 2012, 18:494-500.
24. Treglia G., Cason E., Stefanelli A., Cocciolillo F., Di Giuda D., Fagioli G., et al. MIBG scintigraphy in differential diagnosis of parkinsonism: a meta-analysis. Clin Auton Res 2012, 22:43-55.
25. Hotter A., Esterhammer R., Schocke M.F., Seppi K. Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 2009, 24(Suppl.2):S711-S720.
26. Paviour D.C., Price S.L., Jahanshahi M., Lees A.J., Fox N.C. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006, 21:989-996.
27. Paviour D.C., Thornton J.S., Lees A.J., Jäger H.R. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 2007, 22:68-74.
28. Garciá-Lorenzo D., Longo-Dos Santos C., Ewenczyk C., Leu-Semenescu S., Gallea C., Quattrocchi G. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain 2013, 136:2120-2129.